Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
DICE Therapeutics, Inc. (DICE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Former 10% owners and Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Unknown transaction of 7,070,205 shares
@ $0
Unknown transaction of 786,407 shares
@ $0
Disposed/sold 21,250 options to buy
@ $14.98, valued at
$318.3k
|
|
| 08/09/2023 |
4
| TETLOW SHARON (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 49,841 shares
@ $0
Disposed/sold 12,096 options to buy
@ $17, valued at
$205.6k
Disposed/sold 8,261 options to buy
@ $17, valued at
$140.4k
Disposed/sold 13,800 options to buy
@ $17, valued at
$234.6k
Disposed/sold 21,250 options to buy
@ $14.98, valued at
$318.3k
|
|
| 08/09/2023 |
4
| Simson Jake (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 21,250 options to buy
@ $14.98, valued at
$318.3k
|
|
| 08/09/2023 |
4
| Scopa James Paul (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 15,199 shares
@ $0
Disposed/sold 25,722 shares
@ $0
Disposed/sold 12,096 options to buy
@ $17, valued at
$205.6k
Disposed/sold 8,261 options to buy
@ $17, valued at
$140.4k
Disposed/sold 13,800 options to buy
@ $17, valued at
$234.6k
Disposed/sold 21,250 options to buy
@ $14.98, valued at
$318.3k
|
|
| 08/09/2023 |
4
| Robertson Scott M. (CFO & CBO) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 198,000 shares
@ $0
Disposed/sold 7,191 options to buy
@ $17, valued at
$122.2k
Disposed/sold 771 options to buy
@ $17, valued at
$13.1k
Disposed/sold 20,751 options to buy
@ $17, valued at
$352.8k
Disposed/sold 2,688 options to buy
@ $17, valued at
$45.7k
Disposed/sold 9,095 options to buy
@ $17, valued at
$154.6k
Disposed/sold 16,595 options to buy
@ $17, valued at
$282.1k
Disposed/sold 15,000 options to buy
@ $17, valued at
$255k
Disposed/sold 56,920 options to buy
@ $17, valued at
$967.6k
Disposed/sold 154,250 options to buy
@ $19.64, valued at
$3M
Disposed/sold 112,500 options to buy
@ $32.31, valued at
$3.6M
|
|
| 08/09/2023 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 8,427 shares
@ $0
Disposed/sold 4,357 options to buy
@ $17, valued at
$74.1k
Disposed/sold 9,138 options to buy
@ $17, valued at
$155.3k
Disposed/sold 8,261 options to buy
@ $17, valued at
$140.4k
Disposed/sold 22,600 options to buy
@ $17, valued at
$384.2k
Disposed/sold 31,250 options to buy
@ $14.98, valued at
$468.1k
|
|
| 08/09/2023 |
4
| Timothy Lu (CMO) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 152,285 shares
@ $0
Disposed/sold 31,304 options to buy
@ $17, valued at
$532.2k
Disposed/sold 25,593 options to buy
@ $17, valued at
$435.1k
Disposed/sold 43,167 options to buy
@ $17, valued at
$733.8k
Disposed/sold 157,756 options to buy
@ $19.64, valued at
$3.1M
Disposed/sold 90,000 options to buy
@ $32.31, valued at
$2.9M
Disposed/sold 15,000 restricted stock units
@ $0 |
|
| 08/09/2023 |
4
| Judice Kevin (CEO) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 799,685 shares
@ $0
Disposed/sold 20,464 options to buy
@ $17, valued at
$347.9k
Disposed/sold 16,661 options to buy
@ $17, valued at
$283.2k
Disposed/sold 131,027 options to buy
@ $17, valued at
$2.2M
Disposed/sold 132,074 options to buy
@ $17, valued at
$2.2M
Disposed/sold 384,900 options to buy
@ $19.64, valued at
$7.6M
Disposed/sold 300,000 options to buy
@ $32.31, valued at
$9.7M
Disposed/sold 50,000 restricted stock units
@ $0 |
|
| 08/09/2023 |
4
| Jacobsen John R. (CSO) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 147,497 shares
@ $0
Disposed/sold 4,367 options to buy
@ $17, valued at
$74.2k
Disposed/sold 922 options to buy
@ $17, valued at
$15.7k
Disposed/sold 1,278 options to buy
@ $17, valued at
$21.7k
Disposed/sold 4,229 options to buy
@ $17, valued at
$71.9k
Disposed/sold 1,344 options to buy
@ $17, valued at
$22.8k
Disposed/sold 4,408 options to buy
@ $17, valued at
$74.9k
Disposed/sold 14,341 options to buy
@ $17, valued at
$243.8k
Disposed/sold 7,579 options to buy
@ $17, valued at
$128.8k
Disposed/sold 11,064 options to buy
@ $17, valued at
$188.1k
Disposed/sold 46,324 options to buy
@ $17, valued at
$787.5k
|
|
| 08/09/2023 |
4
| Doyle Mittie (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 42,500 options to buy
@ $19.13, valued at
$813k
|
|
| 08/09/2023 |
4
| Bowers Lisa (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 42,500 options to buy
@ $19.13, valued at
$813k
|
|
| 08/03/2023 |
4
| Scopa James Paul (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Gifted 220 shares
@ $0
Gifted 2,200 shares
@ $0 |
|
| 07/19/2023 |
4
| Scopa James Paul (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Gifted 2,200 shares
@ $0 |
|
| 07/13/2023 |
4
| Scopa James Paul (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Gifted 300 shares
@ $0 |
|
| 06/02/2023 |
4
| Jacobsen John R. (CSO) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Sold 14,307 shares
@ $30.31, valued at
$433.6k
Sold 4,443 shares
@ $31.24, valued at
$138.8k
|
|
| 05/09/2023 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Sold 84,097 shares
@ $38.5056, valued at
$3.2M
|
|
| 05/05/2023 |
4
| Robertson Scott M. (CFO & CBO) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Sold 18,750 shares
@ $36.552, valued at
$685.4k
|
|
| 05/05/2023 |
4
| Timothy Lu (CMO) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $36.5398, valued at
$365.4k
|
|
| 05/05/2023 |
4
| Judice Kevin (CEO) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Sold 13,698 shares
@ $36.5, valued at
$500k
|
|
| 05/02/2023 |
4
| Scopa James Paul (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Gifted 6,923 shares
@ $0
Gifted 6,923 shares
@ $0 |
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Jacobsen John R. (CSO) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Sold 773 shares
@ $30, valued at
$23.2k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Scopa James Paul (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Gifted 30,719 shares
@ $0
Gifted 30,719 shares
@ $0
Sold 10,000 shares
@ $29.05, valued at
$290.5k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Simson Jake (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Granted 21,250 options to buy
@ $14.98, valued at
$318.3k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|